Cochrane · systematic review · CD013117
Ivermectin treatment in humans for reducing malaria transmission
de Souza, DK, Thomas, R, Bradley, J, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
Infectious DiseasesAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
2
current version
GRADE rated
2
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Ivermectin versus control in humans to reduce malaria transmission
Population: adults and children living in malaria‐endemic areas
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Incidence of clinical malaria Ivermectin vs control | no estimate extracted | 590 participants | Very low Downgraded: risk of bias, imprecision, indirectness |
Adverse events Ivermectin vs control | RR 1.63 [1, 2.67] | 2712 participants | Very low Downgraded: risk of bias, imprecision, indirectness |